These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30231345)

  • 1. New Era in the Management of Melanoma Brain Metastases.
    Tawbi HA; Boutros C; Kok D; Robert C; McArthur G
    Am Soc Clin Oncol Educ Book; 2018 May; 38():741-750. PubMed ID: 30231345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Treatment of Melanoma Brain Metastasis.
    Rishi A; Yu HM
    Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
    Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
    Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the systemic treatment of melanoma brain metastases.
    Glitza Oliva IC; Schvartsman G; Tawbi H
    Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
    Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
    Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of systemic therapy in melanoma brain metastases: a narrative review.
    Saleem K; Davar D
    Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of systemic therapies in the management of melanoma brain metastases.
    Lyle M; Long GV
    Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.
    Wang Y; Lian B; Si L; Chi Z; Sheng X; Wang X; Mao L; Tang B; Li S; Yan X; Bai X; Zhou L; Cui C; Guo J
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2731-2740. PubMed ID: 33611636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Melanoma CNS Metastases.
    Jang S; Atkins MB
    Cancer Treat Res; 2016; 167():263-79. PubMed ID: 26601867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in therapy for brain metastases in melanoma patients.
    Wilkes JG; Patel A; McClure E; Pina Y; Zager JS
    Expert Opin Pharmacother; 2021 Aug; 22(11):1443-1453. PubMed ID: 33688795
    [No Abstract]   [Full Text] [Related]  

  • 13. Local and Systemic Management Options for Melanoma Brain Metastases.
    Amouzegar A; Tawbi HA
    Cancer J; 2024 Mar-Apr 01; 30(2):102-107. PubMed ID: 38527263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma brain metastases: an unmet challenge in the era of active therapy.
    Gorantla V; Kirkwood JM; Tawbi HA
    Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel treatments for melanoma brain metastases.
    Kenchappa RS; Tran N; Rao NG; Smalley KS; Gibney GT; Sondak VK; Forsyth PA
    Cancer Control; 2013 Oct; 20(4):298-306. PubMed ID: 24077406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.
    Kuske M; Rauschenberg R; Garzarolli M; Meredyth-Stewart M; Beissert S; Troost EGC; Glitza OIC; Meier F
    Am J Clin Dermatol; 2018 Aug; 19(4):529-541. PubMed ID: 29417399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
    Schvartsman G; Ma J; Bassett RL; Haydu LE; Amaria RN; Hwu P; Wong MK; Hwu WJ; Diab A; Patel SP; Davies MA; Hamerschlak N; Tawbi HA; Glitza Oliva IC
    Cancer; 2019 Dec; 125(23):4193-4202. PubMed ID: 31398264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature and management of metastatic melanoma after progression on BRAF inhibitors: effects of extended BRAF inhibition.
    Chan MM; Haydu LE; Menzies AM; Azer MW; Klein O; Lyle M; Clements A; Guminski A; Kefford RF; Long GV
    Cancer; 2014 Oct; 120(20):3142-53. PubMed ID: 24985732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology and therapeutic management of melanoma brain metastases.
    Abate-Daga D; Ramello MC; Smalley I; Forsyth PA; Smalley KSM
    Biochem Pharmacol; 2018 Jul; 153():35-45. PubMed ID: 29278675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.